The alliance is conceived as an open collaboration platform designed to connect the various actors in the healthcare system —industry, care providers, research institutions, public administration, a...
Pharmacelera, a deep tech company applying Quantum Mechanics and Artificial Intelligence to revolutionize drug discovery based at the Barcelona Science Park (PCB-UB), has closed a €6 million investm...
CRB Bio II acquired a significant stake in 2013 — alongside XesGalicia — and assumed an active role in the company’s strategic direction and corporate development. Under CRB’s leadership, Heal...
Founded to translate cutting-edge neuroscience research into novel ophthalmic solutions, D-Sight is developing first-in-class neuroprotective drugs aimed at preserving retinal neurons and preventing i...
DLA Piper has advised Mérieux Equity Partners on the acquisition of a significant minority stake in Health in Code, a leading Spanish company in genetic diagnostics and advanced solutions based on ne...
Sermes CRO is a Spanish contract research organization (CRO) with 29 years of experience, dedicated to optimizing clinical research processes for pharmaceutical and biotechnology companies, as well as...
The firm is led by two prominent figures in the Spanish healthcare and private equity sectors: Héctor Ciria, former CEO of Quirónsalud, and David Santos, former partner at Alantra Private Equity. Th...
SETT will invest more than 600,000 euros in the Spanish company Robopedics to promote the development of an innovative bionic technology applied to mobility and rehabilitation of people with severe mo...
Endor Technologies is advancing the development of an innovative treatment for metastatic tumors based on a therapeutic paradigm shift. With the support of CDTI Innovación funding and co-financing fr...
Aleos Capital expects to make its first investment in a high‑growth company in the biosciences sector before completing the final closing of the fund, scheduled for the end of this year and which ha...
Nanodecal, with the support of CDTI Innovación through the Neotec program, is working on the PRONTO platform, a solution that will enable the detection of pathogens and biomarkers in a matter of minu...
This initiative will enable Ysios Capital to work more closely with universities, research centers and scientific entrepreneurs to identify innovative biomedical opportunities and support their develo...